Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Biopharmaceutical Third Party Transportation Services Market Overview
Biopharmaceutical third party transportation services refer to transportation services provided by professional logistics companies for biopharmaceutical enterprises, covering the entire logistics solution from production to distribution. This type of services typically include cold chain transportation, warehouse management, and value-added services (such as packaging, labeling, temperature monitoring, etc.) aimed at ensuring the safety, stability, and compliance of biopharmaceutical products (such as vaccines, biologics, gene therapy drugs, etc.) during transportation.
Key Insights & Strategic Takeaways Driving Market Outlook
(1) Global Biopharmaceutical Third Party Transportation Services market size (sales volume & revenue), history data from 2020 - 2025, and forecast data from {2025 to 2031.
(2) Global Biopharmaceutical Third Party Transportation Services market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(3) China Biopharmaceutical Third Party Transportation Services market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(4) Global Biopharmaceutical Third Party Transportation Services segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.
(5) Global Biopharmaceutical Third Party Transportation Services segment by Type, and by Application, and regional segment by Type, and by Application.
(6) Global major production regions of Biopharmaceutical Third Party Transportation Services , capacity, production and trends.
(7) Biopharmaceutical Third Party Transportation Services industry supply chain, upstream, midstream, and downstream analysis.
In-Depth Assessment of Market Segmentation by Geographic Region
➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
Segmentation by Product Type: Analytical Breakdown and Market Relevance
This section presents a comprehensive analysis of the market based on product type, highlighting segment-wise performance indicators, emerging trends, and their strategic implications within the overall industry landscape.
- Vaccine Transportation
- Blood Products Transportation
- Cell And Gene Therapy Products Transportation
- Clinical Trial Drug Transportation
- Drug Distribution And Retail
Market Segmentation by Application
Markets are categorized based on specific application areas, offering insight into usage trends and consumer preferences. This segmentation helps businesses tailor products, services, and strategies to align with diverse industry needs and customer demands.
- Air Transport
- Sea Transportation
- Land Transportation
Market Segmentation by Key Players
This report examines the competitive landscape by categorizing market participants based on their roles, influence, and strategic positioning. Understanding player segmentation helps identify industry leaders, emerging competitors, and collaboration opportunities within the market.
- Kuehne+Nagel
- DHL
- AmerisourceBergen
- McKesson
- Ryder
- Panalpina
- Cegelec
- UPS
- TQL
- C.H. Robinson
- Perry Group
- DB Schenker
- Cardinal Health
- FedEx
- XPO Logistics
- Sinopharm Group
- Huaxin Supply Chain
- SF Express
- Kerry Logistics
- Shanghai Pharma
1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Third Party Transportation Services
1.2 Global Biopharmaceutical Third Party Transportation Services Market Size and Forecast
1.3 China Biopharmaceutical Third Party Transportation Services Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Biopharmaceutical Third Party Transportation Services Share in Global Market, 2020-2031
1.4.2 Biopharmaceutical Third Party Transportation Services Market Size: China VS Global, 2020-2031
1.5 Biopharmaceutical Third Party Transportation Services Market Dynamics
1.5.1 Biopharmaceutical Third Party Transportation Services Market Drivers
1.5.2 Biopharmaceutical Third Party Transportation Services Market Restraints
1.5.3 Biopharmaceutical Third Party Transportation Services Industry Trends
1.5.4 Biopharmaceutical Third Party Transportation Services Industry Policy
2 Competitive Landscape by Company
2.1 Global Biopharmaceutical Third Party Transportation Services Revenue by Company, 2020-2025
2.2 Global Biopharmaceutical Third Party Transportation Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biopharmaceutical Third Party Transportation Services Concentration Ratio
2.4 Global Biopharmaceutical Third Party Transportation Services Mergers & Acquisitions, Expansion Plans
2.5 Global Biopharmaceutical Third Party Transportation Services Manufacturers Product Type
2.6 Global Geographic Distribution of Biopharmaceutical Third Party Transportation Services Companies
3 China Competitive Situation by Company
3.1 China Biopharmaceutical Third Party Transportation Services Revenue by Company, 2020-2025
3.2 China Biopharmaceutical Third Party Transportation Services Biopharmaceutical Third Party Transportation Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Biopharmaceutical Third Party Transportation Services Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
4.1 Biopharmaceutical Third Party Transportation Services Industry Chain
4.2 Biopharmaceutical Third Party Transportation Services Upstream Analysis
4.3 Biopharmaceutical Third Party Transportation Services Midstream Analysis
4.4 Biopharmaceutical Third Party Transportation Services Downstream Analysis
5 Sights by Type
5.1 Biopharmaceutical Third Party Transportation Services Classification
5.1.1 Air Transport
5.1.2 Sea Transportation
5.1.3 Land Transportation
5.2 by Type, Global Biopharmaceutical Third Party Transportation Services Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
6 Sights by Application
6.1 Biopharmaceutical Third Party Transportation Services Segment by Application
6.1.1 Vaccine Transportation
6.1.2 Blood Products Transportation
6.1.3 Cell And Gene Therapy Products Transportation
6.1.4 Clinical Trial Drug Transportation
6.1.5 Drug Distribution And Retail
6.2 by Application, Global Biopharmaceutical Third Party Transportation Services Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
7 Sights by Region
7.1 By Region, Global Biopharmaceutical Third Party Transportation Services Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
7.3 North America
7.3.1 North America Biopharmaceutical Third Party Transportation Services Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Biopharmaceutical Third Party Transportation Services Market Size Market Share
7.4 Europe
7.4.1 Europe Biopharmaceutical Third Party Transportation Services Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Biopharmaceutical Third Party Transportation Services Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biopharmaceutical Third Party Transportation Services Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Biopharmaceutical Third Party Transportation Services Market Size Market Share
7.6 South America
7.6.1 South America Biopharmaceutical Third Party Transportation Services Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Biopharmaceutical Third Party Transportation Services Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Biopharmaceutical Third Party Transportation Services Market Size & CAGR,2020 VS 2024 VS 2031
8.2 By Country, Global Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.3 United States
8.3.1 United States Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.3.2 By Company, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.3.3 by Type, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.4.2 By Company, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.4.3 by Type, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.5.2 By Company, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.5.3 by Type, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.6.2 By Company, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.6.3 by Type, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.7.2 By Company, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.7.3 by Type, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.9.2 By Company, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.9.3 by Type, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Biopharmaceutical Third Party Transportation Services Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
9 Company Profile
9.1 Kuehne+Nagel
9.1.1 Kuehne+Nagel Company Information, Head Office, Market Area, and Industry Position
9.1.2 Kuehne+Nagel Company Profile and Main Business
9.1.3 Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.1.4 Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.1.5 Kuehne+Nagel Recent Developments
9.2 DHL
9.2.1 DHL Company Information, Head Office, Market Area, and Industry Position
9.2.2 DHL Company Profile and Main Business
9.2.3 DHL Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.2.4 DHL Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.2.5 DHL Recent Developments
9.3 AmerisourceBergen
9.3.1 AmerisourceBergen Company Information, Head Office, Market Area, and Industry Position
9.3.2 AmerisourceBergen Company Profile and Main Business
9.3.3 AmerisourceBergen Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.3.4 AmerisourceBergen Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.3.5 AmerisourceBergen Recent Developments
9.4 McKesson
9.4.1 McKesson Company Information, Head Office, Market Area, and Industry Position
9.4.2 McKesson Company Profile and Main Business
9.4.3 McKesson Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.4.4 McKesson Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.4.5 McKesson Recent Developments
9.5 Ryder
9.5.1 Ryder Company Information, Head Office, Market Area, and Industry Position
9.5.2 Ryder Company Profile and Main Business
9.5.3 Ryder Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.5.4 Ryder Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.5.5 Ryder Recent Developments
9.6 Panalpina
9.6.1 Panalpina Company Information, Head Office, Market Area, and Industry Position
9.6.2 Panalpina Company Profile and Main Business
9.6.3 Panalpina Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.6.4 Panalpina Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.6.5 Panalpina Recent Developments
9.7 Cegelec
9.7.1 Cegelec Company Information, Head Office, Market Area, and Industry Position
9.7.2 Cegelec Company Profile and Main Business
9.7.3 Cegelec Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.7.4 Cegelec Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.7.5 Cegelec Recent Developments
9.8 UPS
9.8.1 UPS Company Information, Head Office, Market Area, and Industry Position
9.8.2 UPS Company Profile and Main Business
9.8.3 UPS Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.8.4 UPS Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.8.5 UPS Recent Developments
9.9 TQL
9.9.1 TQL Company Information, Head Office, Market Area, and Industry Position
9.9.2 TQL Company Profile and Main Business
9.9.3 TQL Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.9.4 TQL Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.9.5 TQL Recent Developments
9.10 C.H. Robinson
9.10.1 C.H. Robinson Company Information, Head Office, Market Area, and Industry Position
9.10.2 C.H. Robinson Company Profile and Main Business
9.10.3 C.H. Robinson Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.10.4 C.H. Robinson Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.10.5 C.H. Robinson Recent Developments
9.11 Perry Group
9.11.1 Perry Group Company Information, Head Office, Market Area, and Industry Position
9.11.2 Perry Group Company Profile and Main Business
9.11.3 Perry Group Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.11.4 Perry Group Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.11.5 Perry Group Recent Developments
9.12 DB Schenker
9.12.1 DB Schenker Company Information, Head Office, Market Area, and Industry Position
9.12.2 DB Schenker Company Profile and Main Business
9.12.3 DB Schenker Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.12.4 DB Schenker Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.12.5 DB Schenker Recent Developments
9.13 Cardinal Health
9.13.1 Cardinal Health Company Information, Head Office, Market Area, and Industry Position
9.13.2 Cardinal Health Company Profile and Main Business
9.13.3 Cardinal Health Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.13.4 Cardinal Health Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.13.5 Cardinal Health Recent Developments
9.14 FedEx
9.14.1 FedEx Company Information, Head Office, Market Area, and Industry Position
9.14.2 FedEx Company Profile and Main Business
9.14.3 FedEx Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.14.4 FedEx Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.14.5 FedEx Recent Developments
9.15 XPO Logistics
9.15.1 XPO Logistics Company Information, Head Office, Market Area, and Industry Position
9.15.2 XPO Logistics Company Profile and Main Business
9.15.3 XPO Logistics Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.15.4 XPO Logistics Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.15.5 XPO Logistics Recent Developments
9.16 Sinopharm Group
9.16.1 Sinopharm Group Company Information, Head Office, Market Area, and Industry Position
9.16.2 Sinopharm Group Company Profile and Main Business
9.16.3 Sinopharm Group Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.16.4 Sinopharm Group Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.16.5 Sinopharm Group Recent Developments
9.17 Huaxin Supply Chain
9.17.1 Huaxin Supply Chain Company Information, Head Office, Market Area, and Industry Position
9.17.2 Huaxin Supply Chain Company Profile and Main Business
9.17.3 Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.17.4 Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.17.5 Huaxin Supply Chain Recent Developments
9.18 SF Express
9.18.1 SF Express Company Information, Head Office, Market Area, and Industry Position
9.18.2 SF Express Company Profile and Main Business
9.18.3 SF Express Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.18.4 SF Express Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.18.5 SF Express Recent Developments
9.19 Kerry Logistics
9.19.1 Kerry Logistics Company Information, Head Office, Market Area, and Industry Position
9.19.2 Kerry Logistics Company Profile and Main Business
9.19.3 Kerry Logistics Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.19.4 Kerry Logistics Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.19.5 Kerry Logistics Recent Developments
9.20 Shanghai Pharma
9.20.1 Shanghai Pharma Company Information, Head Office, Market Area, and Industry Position
9.20.2 Shanghai Pharma Company Profile and Main Business
9.20.3 Shanghai Pharma Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
9.20.4 Shanghai Pharma Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, 2020-2025
9.20.5 Shanghai Pharma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Biopharmaceutical Third Party Transportation Services Market Size & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Biopharmaceutical Third Party Transportation Services Market Restraints
Table 3. Biopharmaceutical Third Party Transportation Services Market Trends
Table 4. Biopharmaceutical Third Party Transportation Services Industry Policy
Table 5. Global Biopharmaceutical Third Party Transportation Services Revenue by Company, 2020-2025, US$ million
Table 6. Global Biopharmaceutical Third Party Transportation Services Revenue Market Share by Company, 2020-2025
Table 7. Global Biopharmaceutical Third Party Transportation Services Players Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biopharmaceutical Third Party Transportation Services Mergers & Acquisitions, Expansion Plans
Table 9. Global Biopharmaceutical Third Party Transportation Services Manufacturers Product Type
Table 10. Global Headquarters and Manufacturing Base of Biopharmaceutical Third Party Transportation Services Manufacturers
Table 11. China Biopharmaceutical Third Party Transportation Services Revenue by Company, 2020-2025, US$ million
Table 12. China Biopharmaceutical Third Party Transportation Services Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Biopharmaceutical Third Party Transportation Services Upstream (Raw Materials)
Table 14. Global Biopharmaceutical Third Party Transportation Services Typical Customers
Table 15. by Type, Global Biopharmaceutical Third Party Transportation Services Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 16. by Application, Global Biopharmaceutical Third Party Transportation Services Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. By Region, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2025, US$ Million
Table 19. By Region, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Table 20. By Country, Global Biopharmaceutical Third Party Transportation Services Revenue & CAGR,2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2025, US$ Million
Table 22. By Country, Global Biopharmaceutical Third Party Transportation Services Revenue, 2026-2031, US$ Million
Table 23. By Country, Global Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2020-2025
Table 24. By Country, Global Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2026-2031
Table 25. Kuehne+Nagel Company Information, Head Office, Market Area, and Industry Position
Table 26. Kuehne+Nagel Company Profile and Main Business
Table 27. Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 28. Kuehne+Nagel Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 29. Kuehne+Nagel Recent Developments
Table 30. DHL Company Information, Head Office, Market Area, and Industry Position
Table 31. DHL Company Profile and Main Business
Table 32. DHL Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 33. DHL Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 34. DHL Recent Developments
Table 35. AmerisourceBergen Company Information, Head Office, Market Area, and Industry Position
Table 36. AmerisourceBergen Company Profile and Main Business
Table 37. AmerisourceBergen Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 38. AmerisourceBergen Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 39. AmerisourceBergen Recent Developments
Table 40. McKesson Company Information, Head Office, Market Area, and Industry Position
Table 41. McKesson Company Profile and Main Business
Table 42. McKesson Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 43. McKesson Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 44. McKesson Recent Developments
Table 45. Ryder Company Information, Head Office, Market Area, and Industry Position
Table 46. Ryder Company Profile and Main Business
Table 47. Ryder Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 48. Ryder Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 49. Ryder Recent Developments
Table 50. Panalpina Company Information, Head Office, Market Area, and Industry Position
Table 51. Panalpina Company Profile and Main Business
Table 52. Panalpina Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 53. Panalpina Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 54. Panalpina Recent Developments
Table 55. Cegelec Company Information, Head Office, Market Area, and Industry Position
Table 56. Cegelec Company Profile and Main Business
Table 57. Cegelec Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 58. Cegelec Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 59. Cegelec Recent Developments
Table 60. UPS Company Information, Head Office, Market Area, and Industry Position
Table 61. UPS Company Profile and Main Business
Table 62. UPS Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 63. UPS Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 64. UPS Recent Developments
Table 65. TQL Company Information, Head Office, Market Area, and Industry Position
Table 66. TQL Company Profile and Main Business
Table 67. TQL Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 68. TQL Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 69. TQL Recent Developments
Table 70. C.H. Robinson Company Information, Head Office, Market Area, and Industry Position
Table 71. C.H. Robinson Company Profile and Main Business
Table 72. C.H. Robinson Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 73. C.H. Robinson Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 74. C.H. Robinson Recent Developments
Table 75. Perry Group Company Information, Head Office, Market Area, and Industry Position
Table 76. Perry Group Company Profile and Main Business
Table 77. Perry Group Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 78. Perry Group Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 79. Perry Group Recent Developments
Table 80. DB Schenker Company Information, Head Office, Market Area, and Industry Position
Table 81. DB Schenker Company Profile and Main Business
Table 82. DB Schenker Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 83. DB Schenker Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 84. DB Schenker Recent Developments
Table 85. Cardinal Health Company Information, Head Office, Market Area, and Industry Position
Table 86. Cardinal Health Company Profile and Main Business
Table 87. Cardinal Health Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 88. Cardinal Health Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 89. Cardinal Health Recent Developments
Table 90. FedEx Company Information, Head Office, Market Area, and Industry Position
Table 91. FedEx Company Profile and Main Business
Table 92. FedEx Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 93. FedEx Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 94. FedEx Recent Developments
Table 95. XPO Logistics Company Information, Head Office, Market Area, and Industry Position
Table 96. XPO Logistics Company Profile and Main Business
Table 97. XPO Logistics Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 98. XPO Logistics Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 99. XPO Logistics Recent Developments
Table 100. Sinopharm Group Company Information, Head Office, Market Area, and Industry Position
Table 101. Sinopharm Group Company Profile and Main Business
Table 102. Sinopharm Group Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 103. Sinopharm Group Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 104. Sinopharm Group Recent Developments
Table 105. Huaxin Supply Chain Company Information, Head Office, Market Area, and Industry Position
Table 106. Huaxin Supply Chain Company Profile and Main Business
Table 107. Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 108. Huaxin Supply Chain Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 109. Huaxin Supply Chain Recent Developments
Table 110. SF Express Company Information, Head Office, Market Area, and Industry Position
Table 111. SF Express Company Profile and Main Business
Table 112. SF Express Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 113. SF Express Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 114. SF Express Recent Developments
Table 115. Kerry Logistics Company Information, Head Office, Market Area, and Industry Position
Table 116. Kerry Logistics Company Profile and Main Business
Table 117. Kerry Logistics Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 118. Kerry Logistics Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 119. Kerry Logistics Recent Developments
Table 120. Shanghai Pharma Company Information, Head Office, Market Area, and Industry Position
Table 121. Shanghai Pharma Company Profile and Main Business
Table 122. Shanghai Pharma Biopharmaceutical Third Party Transportation Services Models, Specifications, and Application
Table 123. Shanghai Pharma Biopharmaceutical Third Party Transportation Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 124. Shanghai Pharma Recent Developments
List of Figures
Figure 1. Biopharmaceutical Third Party Transportation Services Picture
Figure 2. Global Biopharmaceutical Third Party Transportation Services Revenue and Forecast, 2020-2031, US$ Million
Figure 3. China Biopharmaceutical Third Party Transportation Services Revenue and Forecast, 2020-2031, US$ Million
Figure 4. By Revenue, China Biopharmaceutical Third Party Transportation Services Share of Global Market, 2020-2031
Figure 5. Global Biopharmaceutical Third Party Transportation Services Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 6. Global Biopharmaceutical Third Party Transportation Services Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 7. China Biopharmaceutical Third Party Transportation Services Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 8. China Biopharmaceutical Third Party Transportation Services Key Participants, Market Share, 2024
Figure 9. China Biopharmaceutical Third Party Transportation Services Revenue, Domestic VS Import Products, Proportion of China Local Companies and Foreign Companies, 2020-2031
Figure 10. Biopharmaceutical Third Party Transportation Services Industry Chain
Figure 11. Air Transport
Figure 12. Sea Transportation
Figure 13. Land Transportation
Figure 14. by Type, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 15. by Type, Global Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2020-2031
Figure 16. Vaccine Transportation
Figure 17. Blood Products Transportation
Figure 18. Cell And Gene Therapy Products Transportation
Figure 19. Clinical Trial Drug Transportation
Figure 20. Drug Distribution And Retail
Figure 21. by Application, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 22. by Application, Global Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2020-2031
Figure 23. By Region, Global Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 24. By Region, Global Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2020-2031
Figure 25. North America Biopharmaceutical Third Party Transportation Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 26. By Country, North America Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 27. Europe Biopharmaceutical Third Party Transportation Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 28. By Country, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 29. Asia Pacific Biopharmaceutical Third Party Transportation Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 30. By Country/Region, Asia Pacific Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 31. South America Biopharmaceutical Third Party Transportation Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 32. By Country, South America Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 33. Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 34. United States Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 35. By Company, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 36. by Type, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 37. by Application, United States Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 38. Europe Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 39. By Company, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 40. by Type, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 41. by Application, Europe Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 42. China Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 43. By Company, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 44. by Type, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 45. by Application, China Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 46. Japan Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 47. By Company, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 48. by Type, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 49. by Application, Japan Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 50. South Korea Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 51. By Company, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 52. by Type, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 53. by Application, South Korea Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 54. Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 55. By Company, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 56. by Type, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 57. by Application, Southeast Asia Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 58. India Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 59. By Company, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 60. by Type, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 61. by Application, India Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 62. Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue, 2020-2031, US$ Million
Figure 63. By Company, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024
Figure 64. by Type, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 65. by Application, Middle East & Africa Biopharmaceutical Third Party Transportation Services Revenue Market Share, 2024 VS 2031
Figure 66. Research Methodology
Figure 67. Breakdown of Primary Interviews
Figure 68. Bottom-up Approaches
Figure 69. Top-down Approaches
Research Methodology:
Biopharmaceutical Third Party Transportation Services Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|